When was CellChorus founded?

CellChorus was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is CellChorus located?

CellChorus is headquartered in Houston, United States. It is registered at 5000 GULF FWY,HOUSTON,TX,77023,101.

How many employees does CellChorus have?

As of Mar 31, 2026, the latest employee count at CellChorus is 14.

Is CellChorus a funded company?

CellChorus is a funded company, having raised a total of $125K across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of CellChorus?

CellChorus' latest funding was a $***** Grant (prize money) round on Apr 16, 2025, with participation from 1 investor.

Where does CellChorus rank among its competitors?

CellChorus ranks 30th amongst 134 active competitors, of which 38 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneering Corporation, which secured $25M in Aug, 2025.

Who are the top competitors of CellChorus?

CellChorus' top competitors include Cellworks, Immuneering Corporation and Life Bit. Among them, Immuneering Corporation secured the most recent funding round in August, 2025.

CellChorus - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of single-cell analysis platform evaluating cell dynamics and interactions. The platform applies visual artificial intelligence to assess cell activation, movement, and cell-to-cell interactions over time. It integrates functional profiling with modalities like single-cell RNA sequencing and flow cytometry. The technology characterizes migration, contact dynamics, cytotoxicity, survival, and biomolecule secretion.

Website: cellchorus.com
Social
Email ID: *****@cellchorus.com
Registered Address: 5000 GULF FWY,HOUSTON,TX,77023,101

Key Metrics

Founded Year

2017

Location

Houston, United States

Stage

Seed

Total Funding

$125K in 8 rounds

Latest Funding Round

Grant (prize money), Apr 16, 2025, $*****

Investors

Y Combinator & 3 more

Ranked

30^th among 134 active competitors

Employee Count

14 as on Mar 31, 2026

Similar Companies

Innovaccer & 2460 more

View CellChorus' full profile

CellChorus is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CELLCHORUS INC. CIN: 32080482311 , United States, Active	Aug 05, 2021	-	-	-

CellChorus has raised a total funding of $125K over 8 rounds. Its first funding round was on 2021. Its latest funding round was a Grant (prize money) round on Apr 16, 2025 for $*****. 1 investor participated in its latest round. CellChorus has 4 institutional investors.

Here is the list of recent funding rounds of CellChorus:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 16, 2025	7750124	Grant (prize money)	9526050	7952397	1925453	5821062
Mar 25, 2025	1080258	Grant (prize money)	3218818	3966467	4420124	HHS
Aug 08, 2024	3149159	Grant (prize money)	8731712	4833693	9958397	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of CellChorus's funding rounds and investors

CellChorus' employee count trend

CellChorus has 14 employees as of Mar 26. Here is CellChorus's employee count trend over the years:

Uncover CellChorus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CellChorus include Cellworks, Immuneering Corporation and Life Bit. Here is the list of Top 10 competitors of CellChorus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 3 others	65/100
2nd	Immuneering Corporation 2019, Cambridge (United States), Public	Provider of an AI-enabled bioinformatics platform for clinical solutions	$79M	Citadel, BlackRock & 5 others	60/100
3rd	Life Bit 2017, London (United Kingdom), Series B	AI and SaaS-based genomics analysis software for drug development	$70.9M	Tiger Global Management, Connect Ventures ... & 13 others	56/100
4th	ICarbonX 2015, Shenzhen (China), Series D	Provider of bioinformatic platforms for health management and drug development	$366M	Wealthking Investments, Tencent & 11 others	55/100
5th	Biostate 2023, Houston (United States), Series A	Developer of generative AI based RNAstate research platform to predict future omics states	$16M	Accel, Catapult & 9 others	55/100
6th	Liquid Biosciences 2017, Aliso Viejo (United States), Series C	Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes	$40.1M	-	54/100
7th	GATC 2020, Irvine (United States), Series B	AI-based omic data analysis platform for researchers and professionals	$38.3M	-	52/100
8th	Codetta 2021, Morrisville (United States), Series A	Online platform for analyzing omics clinical data	$27.3M	Anzu Partners, VC23 & 2 others	52/100
9th	Multiomic Health 2021, London (United Kingdom), Seed	Developer of AI-based multi-omics platform for precision medicine	$8.6M	Fifty Years, Hoxton Ventures & 14 others	51/100
10th	Pluto Biosciences 2020, Denver (United States), Seed	Cloud-based research data management tool for scientists	$8.3M	Silverton Partners, Kickstart	49/100
30th	CellChorus 2017, Houston (United States), Seed	Provider of single-cell analysis platform evaluating cell dynamics and interactions	$125K	NIH, National Science Foundation & 2 others	36/100